125 related articles for article (PubMed ID: 34151845)
1. Lymphocyte C-reactive protein ratio: A new biomarker to predict early complications after gastrointestinal oncologic surgery.
Yildirim M; Koca B
Cancer Biomark; 2021; 31(4):409-417. PubMed ID: 34151845
[TBL] [Abstract][Full Text] [Related]
2. Could lymphocyte to C-reactive protein ratio predict the prognosis in patients with gastric cancer?
Angin YS; Yildirim M; Dasiran F; Okan I
ANZ J Surg; 2021 Jul; 91(7-8):1521-1527. PubMed ID: 33956378
[TBL] [Abstract][Full Text] [Related]
3. Prognostic value of lymphocyte-to-C-reactive protein ratio in patients with gastric cancer after surgery: a multicentre study.
Cheng CB; Zhang QX; Zhuang LP; Sun JW
Jpn J Clin Oncol; 2020 Sep; 50(10):1141-1149. PubMed ID: 32564084
[TBL] [Abstract][Full Text] [Related]
4. Lymphocyte-C-reactive Protein Ratio as Promising New Marker for Predicting Surgical and Oncological Outcomes in Colorectal Cancer.
Okugawa Y; Toiyama Y; Yamamoto A; Shigemori T; Ide S; Kitajima T; Fujikawa H; Yasuda H; Hiro J; Yoshiyama S; Yokoe T; Saigusa S; Tanaka K; Shirai Y; Kobayashi M; Ohi M; Araki T; McMillan DC; Miki C; Goel A; Kusunoki M
Ann Surg; 2020 Aug; 272(2):342-351. PubMed ID: 32675548
[TBL] [Abstract][Full Text] [Related]
5. Lymphocyte-to-C-reactive protein ratio and score are clinically feasible nutrition-inflammation markers of outcome in patients with gastric cancer.
Okugawa Y; Toiyama Y; Yamamoto A; Shigemori T; Ichikawa T; Yin C; Suzuki A; Fujikawa H; Yasuda H; Hiro J; Yoshiyama S; Ohi M; Araki T; McMillan DC; Kusunoki M
Clin Nutr; 2020 Apr; 39(4):1209-1217. PubMed ID: 31155370
[TBL] [Abstract][Full Text] [Related]
6. Clinical utility of lymphocyte to C-reactive protein ratio in predicting survival and postoperative complication for esophago-gastric junction cancer.
Tsujiura M; Yamamoto A; Imaoka H; Shimura T; Kitajima T; Morimoto Y; Kawamura M; Yasuda H; Okita Y; Yokoe T; Okugawa Y; Ohi M; Toiyama Y
Surg Oncol; 2022 Sep; 44():101842. PubMed ID: 36081281
[TBL] [Abstract][Full Text] [Related]
7. First day postoperative values of the neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, and C-reactive protein as complication predictors following gastric oncologic surgery.
Ortiz-López D; Acosta-Mérida MA; Casimiro-Pérez JA; Silvestre-Rodríguez J; Marchena-Gómez J
Rev Gastroenterol Mex (Engl Ed); 2022; 87(2):142-148. PubMed ID: 34794921
[TBL] [Abstract][Full Text] [Related]
8. C-reactive protein can be an early predictor of postoperative complications after gastrectomy for gastric cancer.
Kim EY; Yim HW; Park CH; Song KY
Surg Endosc; 2017 Jan; 31(1):445-454. PubMed ID: 27734201
[TBL] [Abstract][Full Text] [Related]
9. Does the preoperative platelet-to-lymphocyte ratio and neutrophil-to-lymphocyte ratio predict morbidity after gastrectomy for gastric cancer?
Mungan İ; Dicle ÇB; Bektaş Ş; Sarı S; Yamanyar S; Çavuş M; Turan S; Bostancı EB
Mil Med Res; 2020 Feb; 7(1):9. PubMed ID: 32111261
[TBL] [Abstract][Full Text] [Related]
10. Preoperative C-reactive protein and operative blood loss predict poor prognosis in patients with gastric cancer after laparoscopy-assisted gastrectomy.
Ishino Y; Saigusa S; Ohi M; Yasuda H; Tanaka K; Toiyama Y; Mohri Y; Kusunoki M
Asian J Endosc Surg; 2014 Nov; 7(4):287-94. PubMed ID: 25123708
[TBL] [Abstract][Full Text] [Related]
11. First day postoperative values of the neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, and C-reactive protein as complication predictors following gastric oncologic surgery.
Ortiz-López D; Acosta-Mérida MA; Casimiro-Pérez JA; Silvestre-Rodríguez J; Marchena-Gómez J
Rev Gastroenterol Mex (Engl Ed); 2021 Jan; ():. PubMed ID: 33423817
[TBL] [Abstract][Full Text] [Related]
12. C-reactive protein elevation ratio as an early predictor of postoperative severe complications after laparoscopic gastrectomy for gastric cancer: a retrospective study.
Tanaka H; Tamura T; Toyokawa T; Muguruma K; Kubo N; Sakurai K; Ohira M
BMC Surg; 2019 Aug; 19(1):114. PubMed ID: 31429742
[TBL] [Abstract][Full Text] [Related]
13. Clinical implications of the preoperative lymphocyte C-reactive protein ratio in esophageal cancer patients.
Yamamoto A; Toiyama Y; Okugawa Y; Ichikawa T; Imaoka H; Yasuda H; Fujikawa H; Okita Y; Yokoe T; Ohi M
Surg Today; 2021 May; 51(5):745-755. PubMed ID: 33130991
[TBL] [Abstract][Full Text] [Related]
14. Combined analysis of preoperative and postoperative lymphocyte-C-reactive protein ratio precisely predicts outcomes of patients with gastric cancer.
Miyatani K; Sawata S; Makinoya M; Miyauchi W; Shimizu S; Shishido Y; Matsunaga T; Yamamoto M; Tokuyasu N; Takano S; Sakamoto T; Hasegawa T; Saito H; Fujiwara Y
BMC Cancer; 2022 Jun; 22(1):641. PubMed ID: 35690739
[TBL] [Abstract][Full Text] [Related]
15. Neutrophil to Lymphocyte Ratio and C-Reactive Protein as Two Predictive Tools of Anastomotic Leak in Colorectal Cancer Open Surgery.
Mik M; Dziki L; Berut M; Trzcinski R; Dziki A
Dig Surg; 2018; 35(1):77-84. PubMed ID: 28132052
[TBL] [Abstract][Full Text] [Related]
16. Lymphocyte to C-reactive protein ratio could better predict the prognosis of patients with stage IV cancer.
Zhang HY; Xie HL; Ruan GT; Zhang Q; Ge YZ; Liu XY; Tang M; Song MM; Lin SQ; Yang M; Zhang XW; Xu HX; Song CH; Shi HP
BMC Cancer; 2022 Oct; 22(1):1080. PubMed ID: 36266627
[TBL] [Abstract][Full Text] [Related]
17. Lymphocyte-to-C reactive protein ratio as novel inflammatory marker for predicting outcomes in hemodialysis patients: A multicenter observational study.
Chen X; Guo W; Diao Z; Huang H; Liu W
Front Immunol; 2023; 14():1101222. PubMed ID: 36936907
[TBL] [Abstract][Full Text] [Related]
18. The neutrophil-to-lymphocyte ratio (NLR) predicts short-term and long-term outcomes in gastric cancer patients.
Miyamoto R; Inagawa S; Sano N; Tadano S; Adachi S; Yamamoto M
Eur J Surg Oncol; 2018 May; 44(5):607-612. PubMed ID: 29478743
[TBL] [Abstract][Full Text] [Related]
19. Clinical significance of prognostic inflammation-based and/or nutritional markers in patients with stage III gastric cancer.
Toyokawa T; Muguruma K; Yoshii M; Tamura T; Sakurai K; Kubo N; Tanaka H; Lee S; Yashiro M; Ohira M
BMC Cancer; 2020 Jun; 20(1):517. PubMed ID: 32493247
[TBL] [Abstract][Full Text] [Related]
20. Lymphocyte-C-reactive protein ratio with calf circumference could better predict survival of patients with non-metastatic cancer.
Liu XY; Zhang X; Zhang Q; Ruan GT; Xie HL; Liu T; Song MM; Ge YZ; Deng L; Shi HP
Sci Rep; 2023 May; 13(1):7217. PubMed ID: 37137949
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
